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Plasma proteins containing damaged L-isoaspartyl residues are Deamidation of asparaginyl residues and/or isomeriza-
increased in uremia: Implications for mechanism. tion of aspartyl residues in proteins is a spontaneous,
Background. Several alterations of protein structure and postbiosynthetic type of damage (also termed proteinfunction have been reported in uremia. Impairment of a trans-
“fatigue” damage), which manifests itself by the appear-methylation-dependent protein repair mechanism possibly re-
ance of abnormal l-isoaspartyl residues [1].lated to a derangement in homocysteine metabolism is also
present in this condition, causing erythrocyte membrane protein l-isoaspartyl sites are able to destroy local conforma-
damage. Homocysteine may affect proteins via the accumulation tion of proteins and destabilize their structure, thus af-
of its parent compound S-adenosylhomocysteine (AdoHcy), a fecting physicochemical properties, such as solubility,
powerful in vivo methyltransferase inhibitor. However, since
and interfering with biological activity [2–6]. The forma-plasma homocysteine is mostly protein bound, a direct influ-
tion of l-isoaspartyls is increased during cell aging andence on protein structures cannot be ruled out. We measured
in various cell stress models [7], as well as in some patho-the levels of l-isoaspartyl residues in plasma proteins of uremic
patients on hemodialysis. These damaged residues are markers logical conditions, such as anemias caused by intrinsic
of molecular age, which accumulate when transmethylation- erythrocyte defects [8, 9]. l-isoaspartyl residues have
dependent protein repair is inhibited and/or protein instability been also found in diseases such as Alzheimer’s diseaseis increased.
and prion encephalopathies in which the accumulationMethods. l-isoaspartyl residues in plasma proteins were quan-
of altered proteins plays a pathogenetic role [10–13].titated using human recombinant protein carboxyl methyl
transferase (PCMT). Plasma concentrations of homocysteine The enzyme protein l-isoaspartate (d-aspartate)
metabolites were also measured under different experimental O-methyltransferase (PCMT; EC 2.1.1.77) selectively
conditions in hemodialysis patients. recognizes and modifies such deamidated/isomerized
Results. The concentration of damaged plasma proteins was residues, thus promoting the repair of abnormal isopep-increased almost twofold compared to control (controls 147.83 6
tide bonds [1]. PCMT, as well as all other transmethyla-17.75, uremics 282.80 6 26.40 pmol of incorporated methyl
tion enzymes, is powerfully inhibited by S-adenosylho-groups/mg protein, P , 0.003). The major protein involved
comigrated with serum albumin. Although hyperhomocys- mocysteine (AdoHcy), the homocysteine precursor [1].
teinemia caused a redistribution of thiols bound to plasma In this respect, it has been recently demonstrated that
proteins, this mechanism did not significantly contribute to in healthy women, plasma homocysteine, through an in-
the increase in isoaspartyl residues. The S-adenosylmethionine crease of plasma and intracellular AdoHcy, leads to(AdoMet)/AdoHcy concentration ratio, an indicator of the flux
DNA hypomethylation in lymphocytes [14]. In fact,of methyl group transfer, was altered. This ratio was partially
when homocysteine accumulates, hydrolysis of AdoHcycorrected by folate treatment (0.385 6 0.046 vs. 0.682 6 0.115,
P , 0.01), but protein l-isoaspartate content was not. slows down, leading to AdoHcy elevation [1]. PCMT
Conclusions. Plasma protein damage, as determined by pro- also has been utilized as a highly specific enzymic tool
tein l-isoaspartyl content, is increased in uremia. This alter- for the identification and quantitation of isoaspartyl resi-
ation is to be ascribed to an increased protein structural insta- dues in proteins [15].bility, rather than the effect of hyperhomocysteinemia.
Protein carboxyl methyl transferase-dependent mem-
brane protein repair of l-isoaspartyl residues is altered
in erythrocytes of uremic patients on hemodialysis, andKey words: recombinant PCMT, transmethylations, homocysteine,
S-adenosylhomocysteine, hemodialysis. this has been regarded as an effect of hyperhomocys-
teinemia via the accumulation of AdoHcy [16–20].Received for publication June 9, 2000
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the hyperhomocysteinemia, which is characteristic of Human recombinant PCMT
these patients, through AdoHcy, has repercussions in A cDNA clone encoding for the more acidic isoen-
the plasma compartment as well as intracellularly. Partial zyme II of PCMT, from a human brain library, was a
characterization of the affected proteins was carried out. generous gift of Dr. Steven Clarke (Department of Chem-
The possibility that direct formation of homocysteiny- istry and Biochemistry and the Molecular Biology Insti-
lated protein adducts could affect protein composition tute, University of California Los Angeles, Los Angeles,
was tested. CA, USA). For enzyme overexpression into Escherichia
Protein damage and the S-adenosylmethionine coli and purification, the method described by MacLaren
(AdoMet)/AdoHcy concentration ratio, a reliable indi- and Clarke was followed, with minor modifications [15].
cator of the flux of methyl group transfer, was also mea- Briefly, E. coli strain DH5a was used for cloning and
sured after a two-month course of folate therapy to verify
propagation of plasmid constructs. For PCMT overex-whether homocysteine reduction is able to modify these
pression, E. coli strain BL21(DE3) was transformed withparameters.
pDM2x expression plasmid and grown in Luria-Bertani
medium, in the presence of 100 mg/mL ampicillin. PCMT
METHODS was purified from transformed bacteria basically as de-
scribed by MacLaren and Clarke [15], except that thePatients and treatment
original DEAE-cellulose chromatography final step, un-Controls were volunteer healthy subjects recruited
der nonequilibrium conditions, was replaced by Q-Seph-among hospital staff. End-stage renal disease patients
arose HP chromatography, using a Hiload 26/10 columnwere selected, provided that they were not affected by
(Pharmacia, Uppsala, Sweden). Column was equilibratedsystemic diseases such as lupus erythematosus, arterial
with buffer A (20 mmol/L Tris-HCl, 0.2 mmol/L EDTAhypertension antecedent to renal disease, diabetes melli-
disodium salt, 10% wt/vol glycerol, 15 mmol/L b-mercap-tus, and cardiac disease. Patients were under regular
toethanol, 25 mmol/L phenylmethylsulfonyl fluoride,bicarbonate hemodialysis treatment, three times weekly,
0.1 mol/L NaCl, pH 8.0). After sample loading (10 mL,utilizing non-reusable hollow-fiber dialyzers. Kt/V was
6 mg/mL protein concentration), the column was washedroutinely checked at monthly intervals, following the
with 10 volumes of buffer A (at 1 mL/min flow rate),NKF-DOQI recommendations, and it was always above
1.4 during the study and in the previous six months. followed by a linear gradient from 0.1 to 0.7 mol/L NaCl
Patients did not consume any B complex vitamins or over 210 minutes. PCMT activity was detected by means
phosphodiesterase inhibitors for a washout period of of the radiochemical assay described by Macfarlane, us-
two months [21]. Methyltetrahydrofolate (MTHF) was ing ovalbumin as a standard methyl-accepting substrate
administered for two months at the dose of 15 mg/day [21]. One enzyme unit is defined as 1 pmol methyl groups
per mouth. Compliance with treatment was assessed by transferred 3 min21.
pill count. Informed consent was obtained from each
patient. Patients did not mention any unusual symptoms In vitro transmethylation assay of plasma proteins
during the study period. l-isoaspartyl residues in proteins can be directly de-
Blood was drawn by venipuncture immediately before tected by an in vitro assay using PCMT as an enzymic
the dialysis session in hemodialysis patients when in a probe with selective substrate specificity toward such
fasting state using ethylenediaminetetraacetic acid (EDTA; damaged aspartyl residues [15]. Damaged residues were
1 mg/mL of blood). Whole blood was immediately centri- specifically recognized and methyl esterified by PCMT,
fuged to separate plasma from cells. Plasma aliquots were using radiolabeled AdoMet as the methyl donor, under
stored at 2808C before analysis.
conditions designed to insure complete labeling, on a 1:1Routine blood biochemical tests (BM/Hitachi 911, F.
molar ratio, of accessible damaged residues in proteins.Hoffmann-La Roche Ltd., Basel, Switzerland) including
This method has proven highly sensitive, specific, repro-urea, creatinine, glucose, total protein, albumin, and
ducible, and particularly suitable when analysis of deami-electrolyte concentrations, were performed before and
dated protein mixtures is to be carried out [22].after treatment.
Methylation of plasma proteins was performed in vitro
in a 90 mL final assay volume containing approximatelyMaterials
1 mg plasma proteins (15 mL), 80 units of PCMT enzymeS-adenosyl-l-[methyl-3H]methionine [specific activity
(5 mL), 47.07 mmol/L of [methyl-14C]AdoMet (10 mL),(sp. act) 500 mCi/mmol] and S-adenosyl-l-[methyl-14C]
and 60 mL of 0.4 mol/L sodium citrate buffer, pH 6.0.methionine (sp. act 50 mCi/mmol) were purchased from
The mixture was incubated at 378C for 90 minutes. UnderAmersham International (Little Chalfont, Buckingham-
these conditions, extensive methyl esterification of plasmashire, UK). All standards and reagents were from Sigma
proteins was achieved. The reaction was stopped by add-Chemical Co. (St. Louis, MO, USA) and were of the
purest grade available. ing 90 mL of quench solution [0.2 mol/L NaOH, 1%
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sodium dodecyl sulfate (SDS)]. One hundred thirty-five plasma proteins, a commercial system commonly avail-
able for clinical diagnostic purposes was employed (Hel-microliters were spotted on filter paper for the vapor
diffusion assay and were read with a scintillation counter ena Laboratories Ltd., Beaumont, TX, USA), using a
Barbital/Tris buffer system at pH 8.8 on a cellulose ace-after two hours, as previously described [16]. Results
are expressed as pmol incorporated methyl groups/mg tate support.
Protein band detection. Gels were then cut into halvesprotein. For this purpose, the specific activity of [methyl-
14C]AdoMet was corrected for the dilution due to endog- and each was loaded with parallel samples. One half was
stained with Coomassie brilliant blue and subjected toenous AdoMet concentration in individual plasma sam-
ples, if not previously diafiltrated. band densitometry using a Pharmacia/LKB Ultro Scan
XL laser densitometer (Pharmacia). The second half wasIn preparation for SDS-polyacrylamide gel electropho-
resis (SDS-PAGE) analysis, plasma proteins were methyl sliced into 2 mm fractions, and radioactivity was deter-
mined after protein elution using 0.4 mL of 50 mmol/Lesterified as described previously in this article, except
that the vapor diffusion step was omitted, and protein sodium acetate buffer, 0.25% Triton X-100, pH 5.2, and
incubated overnight at room temperature under constantsamples were loaded onto the gels after treatment with
sample buffer, as detailed later in this article. [methyl-14C] shaking [16]. Samples were then counted for radioactiv-
ity. Data were expressed as pmol of incorporated methylAdoMet was replaced by [methyl-3H]AdoMet (4 mL
added to a 44.44 mmol/L final concentration into the groups/band area. In some experiments, protein methyl
esters were evaluated, after gel drying under vacuum,assay) for methylation of samples to be analyzed by
SDS-PAGE, followed by either fluorography or gel cut, by means of either fluorography (Amplify; Amersham
International) or gel imaging by electronic autoradiogra-extraction, and protein methyl esters quantitation by
scintillation counting [16]. phy (Instant Imager-Electronic Autoradiography; Pack-
ard Inc., Camberra, Australia).
Electrophoresis analysis of methylated plasma proteins
Determination of homocysteine concentrationSDS-PAGE. SDS-PAGE of methylated plasma pro-
teins was performed according to the general procedure Homocysteine concentration was determined accord-
ing to the method of Ubbink, Vermaak, and Bissbortof Fairbanks, Steck, and Wallach [23], with some modifi-
cations; 1.5 mm thick gels, containing acrylamide 5.6% [25], as modified by Perna et al [17]. Homocysteine repre-
sented the total protein-bound and non-protein–bound(wt/vol) and bisacrylamide 0.2% (wt/vol), in the presence
of 1% SDS, pH 7.4, were used. Samples containing ap- homocysteine. Briefly, the procedure involves a prelimi-
nary step of reduction and release from plasma proteins,proximately 70 mg of proteins were diluted 1:4 with SDS
reducing buffer (62.5 mmol/L Tris-HCl, pH 6.8, 10% using tri-n-butyl-phosphine in dimethylformamide, fol-
lowed by precolumn derivatization with ammoniumvol/vol glycerol, 2% wt/vol SDS, 0.71 mol/L b-mercapto-
ethanol, 0.01% wt/vol Bromophenol blue) and incubated 7-fluorobenzo-2-oxa-1, 3-diazole-4-sulfonate (SBD-F).
Separation was accomplished on a C18, 5 mm, 250 3at 378C for 15 minutes. Samples were run under constant
voltage mode (120 V), using a vertical slab gel unit, which 4.6 mm, reverse phase column (“Luna”; Phenomenex,
Torrance, CA, USA). The mobile phase was 0.1 mol/Lwas purchased from Hoefer Scientific Instruments (San
Francisco, CA, USA). KH2PO4, pH 2.1, containing 4% acetonitrile, with a flow
rate of 1.0 mL/min. Micromolar concentrations of homo-Nondenaturing PAGE. Continuous PAGE under non-
denaturing conditions was also employed, after in vitro cysteine are referred to 1 L of plasma. Detection condi-
tions were optimized for homocysteine. Fluorescence in-methyl esterification with recombinant PCMT. This sys-
tem reproduced the general protocol of Fairbanks and tensities were measured with excitation at 385 nm and
emission at 515 nm, using a Shimadzu RF-535 fluores-Avruch, in the presence of 50 mmol/L final (H3/Na2H2)PO4
buffer at pH 2.4 [24]. The procedure was carried out in cence detector (Shimadzu Co., Kyoto, Japan), equipped
with a Shimadzu Chromatopac C-R6A data processor.the absence of SDS and dithioerythritol and without
protein denaturation prior to sample loading. Horizontal
Effect of homocysteine binding on plasma proteinsresolving gels were poured, containing 10% total acryl-
amide (acrylamide:bisacrylamide 40:1.5 ratio), and pho- Homocysteinylation of plasma proteins can theoreti-
cally affect protein structure directly, thus bypassingtopolymerized. Protein samples were run at 150 V under
constant voltage conditions. This system allowed recov- AdoHcy accumulation and transmethylation inhibition
or other postulated mechanisms of homocysteine toxic-ery of nondenatured proteins from gel slices, which could
be analyzed on cellulose acetate electrophoresis, as de- ity. To test this possibility, 0.8 mL of plasma from control
healthy individuals (mean homocysteine plasma concen-scribed later in this article. Native plasma proteins there-
fore could be identified on an acetate cellulose system tration 5 5 mmol/L) were incubated with or without
100 mmol/L of d-l-homocysteine for the indicated timewithout any interference caused by SDS traces.
For further standard electrophoresis separation of periods at 378C. The assay mixture was then diafiltrated
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with Centricon YM-10 filters, 10,000 molecular weight within 15 minutes. Recovery, calculated by adding trace
amounts of S-adenosyl-[methyl-3H]-methionine to plasmacut-off (Amicon, Millipore, Bedford, MA, USA), with
a Beckman Model J2-21 centrifuge, 5000 3 g for 30 samples, processed in parallel, was complete. Retention
times of the compounds of interest was 10 minutes forminutes. Protein-containing retentate was then washed
twice with buffered saline solution. After diafiltration, etheno-AdoMet and 2 minutes for etheno-AdoHcy.
Condition B. To optimize conditions for etheno-the first diafiltrate and the retentate were analyzed for
their content in homocysteine, cysteine (Cys), and the AdoHcy analysis, the chromatographic system was re-
versed by using an Ultrasil CX column (particle size 10cysteinylglycine (CysGly) dipeptide. Results were cor-
rected for the final volumes of retentate and diafiltrate. mm, 25 3 4.6 mm; Beckman Inc.), with a guard column
(4.5 3 3.2 mm) filled with the same packing material. ThePlasma proteins were also subject to the PCMT-cata-
lyzed in vitro methylation and vapor diffusion assay, as column was equilibrated with a 0.25 mol/L ammonium
formiate buffer, adjusted to pH 4.0 with formic acid, atdescribed previously in this article. Methylation results
are the mean 6 SE of triplicate determinations. a 1.5 mL/min flow rate [28]. Etheno-AdoHcy was eluted
with a 7.8-minute retention time.
High-performance liquid chromatography Peak assignment was accomplished by three methods
determination of plasma AdoHcy and AdoMet in combination: (1) comparison with etheno-derived ex-
ternal standards of AdoMet and AdoHcy; (2) additionSince plasma concentrations of AdoMet and AdoHcy
were expected to be in the 0.2 to 0.6 mmol range [26], of an internal standard of AdoMet and AdoHcy etheno
derivatives; (3) for AdoMet, plasma was treated with cath-to obtain the etheno derivatives of both nucleotides,
precolumn derivatization was performed according to ecol O-methyltransferase, EC 2.1.1.6 (10 U of cathecol
O-methyl transferase was added to 1 mL of plasma inthe general procedure of Wagner et al [27], with some
modifications. Ten percent of 0.625 mL of perchloric the presence of saturating concentrations of the methyl
accepting substrate, protocatechuic acid 0.1 mmol/L, andacid was added to 1 mL of thawed plasma and vortexed.
After centrifugation at 12,000 3 g for 10 minutes, the 0.05 mmol/L MgCl2, and the mixture was incubated at
378C for 1 hour), and processed as described previouslysupernatant was filtered through a Millipore membrane
(0.22 mm). Two hundred microliters of filtered samples in this article.
were treated with 50 mL of chloracetaldehyde, and pH
Statistical analysiswas adjusted to 3.5-4.0 by the addition of 50 mL of 3
mol/L sodium acetate. Samples were then derivatized by Statistical analysis was performed employing the Stu-
dent unpaired or paired t test, as appropriate. Linearincubation at 398C for eight hours, and the reaction was
stopped by ice cooling. regression analysis was done to assess the independent
effects of the different variables [29]. All calculationsA System Gold Solvent Module High-performance
liquid chromatography system (model 126; Beckman In- were performed using the software package SPSSt
(SPSS Inc., Chicago, IL, USA), running on an IBM-struments, Inc., Palo Alto, CA, USA) controlled by a
System Gold software package, running on an IBM PS2 compatible personal computer. All results are presented
as the mean 6 SE.personal computer, was used. Fluorescence of etheno
derivatives was measured with excitation at 270 nm and
emission at 410 nm, using a Shimadzu RF-535 fluorescence
RESULTS
detector (Shimadzu Co.) equipped with a Shimadzu Chro-
Molecular “fatigue” damage in plasma proteins ofmatopac C-R6A data processor. 1,N6-etheno-AdoMet
uremic patients on hemodialysisand 1,N6-etheno-AdoHcy concentrations were measured
separately under different conditions by a combination Levels of l-isoaspartyl residues were measured in
plasma samples from hemodialysis patients and fromof the methods reported by Loehrer et al [26] and Della
Ragione et al [28], respectively, with some modifications, healthy controls. Figure 1 shows a significant increase of
damaged aspartyl residues in hemodialysis patients (N 5according to two experimental conditions.
Condition A. Etheno-AdoMet separation [26] was ob- 15) compared with controls (N 5 9). The mean value in
uremic patients was almost double the value in controls.tained on a 4.0 3 200 mm Hypersil RP-18 (particle size
3 mm) column with a guard column (4.0 3 20 mm) filled
Major damaged plasma protein in hemodialysiswith the same packing material (MZ analyzentechnik,
patients comigrates with albuminMainz, Germany). The column was equilibrated with a
0.1 mol/L sodium acetate buffer containing 0.5 mmol/L Plasma proteins from hemodialysis patients, as well
as from normal controls, were methyl esterified in vitroheptanesulfonic acid and 5.9% vol/vol acetonitrile. After
40 minutes of isocratic elution (0.7 mL/min flow rate), by PCMT and analyzed by means of SDS-PAGE or non-
denaturing PAGE, as described in the Methods section.the column was flushed with 100% acetonitrile for 10
minutes, followed by re-equilibration to initial conditions Methyl esters incorporated into proteins were quanti-
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fied protein in uremia comigrated with serum albumin
(Fig. 3B). Fluorography also allowed the identification
of methyl-esterified serum albumin (comigrating with
the molecular weight standard of 66.00 kD) and five
other minor radioactive protein bands with a molecular
mass of 134, 53, 50, 34, 28 kD, respectively (Fig. 3C).
A quantitative estimate of the methylation stoichiom-
etry of albumin could be made from data accessible from
individual analyses as in Figure 2, taking into account the
patients’ albumin concentration (available from routine
blood testing) and the percentage of incorporated methyl
esters comigrating with albumin compared with the total.
This estimate provided a stoichiometry of 0.078 6 0.005
mol of methyl esters incorporated/mol of albumin in the
uremic versus 0.017 6 0.003 mol/mol in the normal.
Effects of homocysteine on in vitro protein
methylation levels
Plasma homocysteine concentration in hemodialysis
Fig. 1. Protein damage measured with human recombinant protein patients was significantly elevated compared with con-
L-isoaspartate (D-aspartate) O-methyltransferase (PCMT) assay. Plasma
trols (control, 11.06 6 0.75 mmol/L, N 5 8; uremic pa-protein content of l-isoaspartyl residues was quantitated by means of
specific radioenzymatic assay employing human recombinant PCMT tients, 69.44 6 16.46 mmol/L, N 5 13; unpaired t test, P ,
(Methods section) in control and hemodialysis patients. Control N 5 0.01). We verified the hypothesis that direct exposure of9, uremic N 5 15. *P , 0.003 (unpaired t test).
proteins to elevated homocysteine levels may induce an
increase of aspartyl-damaged sites. Plasma from normal
individuals was incubated in the presence of homocys-tated by gel cut, overnight protein elution, and scintilla-
tion counting; an example is given in Figure 2A. The teine at concentrations comparable to those detected in
uremic patients. Evaluation of l-isoaspartyl content wasmost heavily affected protein comigrated with serum
albumin (Fig. 2A). The values of albumin methyl esters accomplished by an in vitro PCMT methylation assay of
plasma protein samples preincubated without or withobtained in this set of experiments were normalized by
protein band area (Fig. 2B). The results in Figure 2 homocysteine for different time periods, and freed from
unbound thiols by diafiltration prior to the PCMT assay.demonstrate that the radioactive methyl incorporation
in proteins was higher in the uremic plasma samples, No increase in the normal plasma protein methyl-
accepting capability, which was specifically induced byconfirming that most radioactivity incorporated as pro-
tein methyl esters comigrated with albumin. homocysteine in the medium, could be detected (Fig.
4A). An increase in protein methylation was observedFigure 2B therefore depicts the pmol of methyl groups
relative to the protein comigrating with albumin, normal- in both treated and untreated samples after several hours
of incubation, likely caused by in vitro deamidation/ized per area of the relevant protein band obtained from
the stained electrophoretic profile. In uremia, the in- isomerization of plasma proteins. This increase in vitro
never approached the levels observed in uremic plasma,crease of isoaspartyl content of the protein comigrating
with albumin with respect to control was greater when indicating that normally plasma proteins in vivo are ef-
fectively protected against deamidation.compared with the average increase in total plasma pro-
teins. On the other hand, it is worth noting that radio- A methionine load significantly increases homocys-
teine plasma levels in healthy subjects. This situation isactivity associated with the other peaks shows little dif-
ference between uremic and control (Fig. 2A). This slightly closer to physiological conditions compared with
the in vitro homocysteine addition to normal plasma.indicates that (1) not all proteins in plasma are subject
to the same increase in isoaspartyl content in uremia, The effect of a methionine load on plasma protein deami-
dation was checked, and the results showed no specificand (2) proteins comigrating with albumin in uremia are
selective targets for isoaspartyl formation compared with acute effect of homocysteine on plasma protein damage
(Fig. 4B).other proteins.
Analysis of methyl esterified proteins was also accom- After two hours of incubation in the presence of homo-
cysteine, protein-bound thiols were concomitantly evalu-plished by a nondenaturing gel electrophoresis system
and radioactive band detection by electronic autoradiog- ated by means of high-performance liquid chromatogra-
phy. Chromatographic analysis allowed an evaluation ofraphy (Fig. 3A). Re-analysis by cellulose acetate electro-
phoresis further confirmed that the major methyl esteri- protein-bound thiols (namely Cys, CysGly, and homocys-
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Fig. 2. Identification of methyl-labeled plasma proteins in uremics (s) and controls (d). Plasma proteins from both normal controls and hemodialysis
patients were methylated in vitro by human recombinant PCMT, as a specific marker reaction for l-isoaspartyl residues, using [3H-methyl]AdoMet.
Duplicate samples of methyl-labeled plasma proteins were then separated by SDS-PAGE. Gel halves were processed in parallel. One half was
Coomassie blue stained for protein molecular mass determination. In the other gel half, individual lanes were dissected into 2 mm slices; proteins
were extracted and samples were counted for radioactivity. (A) The arrow points to the position of standard serum albumin. (B) Values of albumin
methyl esters were normalized by protein area, measured by means of laser densitometry of Coomassie blue-stained profile of electrophoresis
separated protein bands.
teine) in plasma incubated for two hours at 378C without
and with homocysteine. Analysis of protein-bound and
-unbound thiols in samples incubated without homocys-
teine showed that almost all plasma homocysteine bound
to proteins. In the sample incubated with homocysteine,
the proportion of free homocysteine increases. After a
correction for the final volumes of retentate (,800 mL)
and diafiltrate (,1300 mL), protein-bound homocysteine
represented approximately 99% and 68% of the total in
samples incubated without and with homocysteine, re-
spectively. Protein-bound Cys and the dipeptide CysGly
decreased in the sample incubated with homocysteine
compared with the sample in the absence of homocysteine.
After correction for the final volume, protein-bound Cys
and CysGly were 49% (Cys) and 44% (CysGly) in the
high homocysteine sample and 86% (Cys) and 81%Fig. 3. Characterization of methyl-labeled, isoaspartyl-containing, dam-
aged plasma proteins in uremia. Plasma proteins from hemodialysis (CysGly) in the low homocysteine samples.
patients were methylated in vitro using PCMT and [14C-methyl]AdoMet.
Radiolabeled proteins were then separated by PAGE under nondena- The AdoMet/AdoHcy ratio is an in vivo marker ofturing conditions and visualized by electronic autoradiography (A). The
homocysteine derangement, but not of plasmaradioactive protein band was excised, extracted from the gel slice, and
re-analyzed on cellulose acetate electrophoresis system (B), where it co- protein damage
migrated with albumin, when compared with a profile of total plasma
The AdoMet/AdoHcy ratio is altered in uremia bothproteins (lane 1 and 2, respectively). Results were further confirmed
by methylating a parallel plasma protein sample with PCMT, in the pres- in the intracellular compartment [16] and in plasma,
ence of [3H-methyl] AdoMet, followed by SDS-PAGE analysis and
where it is thought to reflect mainly the metabolism ofdetection of radioactive protein bands by fluorography (C; arrows indi-
cate the molecular weight based on the position of protein standards). these two compounds in the liver [26].
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Fig. 4. In vitro and in vivo acute homocys-
teine effects on plasma protein methylation.
(A) Plasma from normal volunteers was incu-
bated with dl-homocysteine (100 mmol/L; )
and without (j), at 378C for the indicated
times. At the end of incubation, plasma pro-
teins were diafiltrated, and the recombinant
PCMT assay was performed. Closed circle sym-
bol points to the mean methylation value of
uremic diafiltrated plasma proteins (homocys-
teine concentration: 44.05 6 0.94). (B) The
effects of acute hyperhomocysteinemia on
plasma protein deamidation and isomeriza-
tion were evaluated by PCMT assay after a
methionine load performed in three normal
subjects (homocysteine concentration before
load 10.9 6 0.47 and after load 32.26 6 0.79).
Symbols are: ( ) fasting; (h) post-methio-
nine loading. The oral methionine load was
performed by administering 100 mg of
methionine/kg diluted in fruit juice. Blood
samples were drawn before and after four
hours, and samples were subjected to homo-
cysteine analysis and the PCMT-catalyzed
assay. Plasma samples to be assayed for PCMT
were diafiltrated as in (A).
Fig. 5. Plasma AdoMet, AdoHcy, and Ado-
Met/AdoHcy ratio before (h) and after (j)
folate administration to uremic patients. Plasma
concentrations of AdoMet and AdoHcy were
measured in uremic hemodialysis patients be-
fore and after folate treatment. Results are
expressed as concentrations of both nucleo-
sides (A), as well as the AdoMet/AdoHcy ra-
tio (B; N 5 13, *P , 0.04; **P , 0.01).
Folates have clear-cut lowering effects on plasma homo- AdoMet/AdoHcy values also are included in Figure 5.
The mean before therapy was 0.385 6 0.045 and after wascysteine levels in hemodialysis patients and significantly
ameliorate the AdoMet/AdoHcy ratio in erythrocytes 0.682 6 0.115 (P , 0.01). Results indicate that upon folate
administration (1) homocysteine is effectively removed[20]. In the present study, the homocysteine concentra-
tion in uremic patients was 69.44 6 16.46 mmol/L and by remethylation to methionine, and (2) metabolic con-
ditions sustain the flow of transmethylations through anafter folate intake was 17.47 6 2.61 mmol/L (N 5 13,
increased AdoMet concentration and AdoMet/AdoHcyP , 0.005, paired t test).
ratio.The plasma AdoMet concentration before and after
therapy with folates was measured (Fig. 5). Mean values
Protein damage after folate therapybefore therapy were 0.268 6 0.058 mmol/L and after
folates were 0.381 6 0.052 mmol/L, P , 0.04. Levels of plasma protein damage were also measured
by the in vitro protein methylation assay after folate ad-The AdoHcy concentration before and after folate
administration was measured, and data are shown in ministration in uremic patients. Results show that methyl
esterification of plasma proteins was not significantly mod-Figure 5. Mean values before therapy were 0.776 6 0.218
mmol/L and after were 0.709 6 0.111 mmol/L (P 5 NS). ified after folate administration (before folate 289.20 6
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of the repair process, complemented by data fitting in
computer-aided mathematical models [18].
Protein carboxyl methyl transferase under normal
conditions is an intracellular enzyme, even if the elegant
work by Weber and McFadden showed that after endo-
thelial injury, altered aspartyl residues of type I and
type III collagen become methylated by PCMT, which
is released into the extracellular space [30, 31]. However,
circulating proteins are not selectively hypermethylated
in vitro in PCMT knockout mice [32]. This indicates that
during their passage in circulation, plasma proteins are
not accessible to this modification unless some type of
cell or tissue stress takes place.
Fig. 6. Effect of folate administration on in vitro methylation of plasma The aim of our study was to determine the isoaspartyl
proteins in uremic patients. Plasma proteins, enzymatically methyl la- content of extracellular proteins in uremia, which couldbeled by means of PCMT in the presence of [14C-methyl]AdoMet, were
be more prone to this kind of damage than intracellularanalyzed by means of SDS-PAGE and were subjected to gel imaging
by electronic autoradiography. Lane 1, normal healthy control; lane 2, proteins.
uremic patient before folate treatment; and lane 3, uremic patient after In this respect, other types of postbiosynthetic proteinfolate treatment.
damage have been described in uremia [33, 34]. In addi-
tion, a self-limited cell breakage, not measurable with
the usual markers of endothelial damage, cannot be ruled
out in uremia. Furthermore, protein deamidation can oc-30.08, after folate 266.84 6 21.90 pmol/mg protein; paired
cur before proteins enter the bloodstream or be the resultt test, N 5 13, P 5 NS). This observation was further
of reduced protein stability, rather than impaired repair.validated by the SDS-PAGE analysis of in vitro methyl-
Several conditions may be simultaneously operative.ated plasma proteins (Fig. 6), confirming that (1) major
As to the causes underlying this kind of damage ofisoaspartyl-containing plasma proteins comigrated with
plasma proteins in uremia, the inhibition of protein re-albumin both in normal and uremic patients, and (2) the
pair does not seem to be involved because the plasmaisoaspartyl content of this plasma protein component is
AdoMet/AdoHcy ratio was ameliorated by folate ther-evidently increased in uremia (Fig. 6, lane 2 vs. lane 1),
apy, but protein l-isoaspartyl content was not. This find-with a slight tendency to decrease after folate treatment
ing can be interpreted that AdoHcy does not play a role(Fig. 6, lane 3 vs. lane 2).
in the isoaspartyl levels in plasma proteins, but it acts
prevalently in cell proteins, as shown in our previous
work [16–20]. Direct binding of homocysteine to proteinsDISCUSSION
does not appear to be involved either.The key finding of the present study is that damaged
A number of uremic toxins are present in plasma andplasma proteins are significantly increased in hemodialy-
in the intracellular compartment at concentrations, whichsis patients. The protein that is most affected comigrates
may modify protein stability, and the intracellular andwith albumin under different analytical conditions. Di-
the extracellular environment may be affected by therect binding of homocysteine to proteins is not responsi-
physicochemical stresses appropriate of uremia (acido-ble for this type of alteration. Although folate therapy
sis, hemodialysis, etc.). In addition, the elevation ofis able to reduce homocysteine levels and favorably affect
plasma protein isoaspartyl content in uremia may reflect
the AdoMet/AdoHcy ratio, it did not significantly modify the presence of more long-lived, aged proteins in circula-
the levels of damaged plasma proteins, at least under the tion. However, we think this possibility is rather unlikely
conditions employed in this study. This indicates that pro- because protein catabolism is frequently increased in
tein damage is not substantially mediated by the methyl- uremia [35], although the isopeptide bond is resistant to
ation inhibition caused by AdoHcy. proteolytic cleavage [22].
The physiological role of PCMT in vivo is linked to Therefore, plasma proteins in uremia may be “prema-
the repair/disposal of damaged proteins [1]. In uremic turely” aged, either because of reduced repair (before
patients, methylation of erythrocyte membrane proteins secretion) or because of increased instability caused by
is reduced in intact cells. This is due to the inhibition the microenvironment. Data in the present manuscript
exerted by increased AdoHcy concentration, caused by to some extent support the second hypothesis. In light
homocysteine elevation [17]. An abnormal accumulation of these findings, a new hypothesis is proposed: Damaged
of l-isoaspartyl residues in red cell membrane proteins residues are present in plasma proteins probably because
the uremic milieu causes premature protein aging.was evaluated in uremia by quantitating side products
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Molecular alterations in the form of isomerized aspar- proteins is not influenced by the direct binding of homo-
cysteine to plasma proteins. Our data confirm that homo-tyl residues, generated through deamidation of asparagi-
nyl residues or isomerization of aspartyl residues, may cysteine binding to plasma proteins induces a significant
redistribution of bound thiols, but it is not sufficient toaccumulate in proteins in vivo [18]. These modifications
may play a pathogenetic role in diseases in which altered increase content of altered aspartyl residues per se.
The l-isoaspartyl content of plasma proteins is notproteins accumulate. This is the case of Alzheimer’s dis-
ease, in which the isoaspartyl content of b-amyloid has significantly modified by folate treatment, under conditions
in which other homocysteine metabolic parameters—thatbeen related to the aging of brain lesions [36]. Isomerized
and/or racemized aspartyl residues lead to significant is, homocysteinemia, and [AdoMet]/[AdoHcy]—are re-
markably affected. This indicates that, in line with previ-changes in the chemical-physical properties (aggregation,
solubility) of b-amyloid [10, 11, 37]. Isomerized aspartyl ous results on animal models, plasma proteins are not
significantly recognized and repaired in vivo by endoge-residues also have been detected in prion proteins, gener-
ating altered forms of these macromolecules [12, 13]. nous PCMT, at least from the moment of their secretion
into the bloodstream [32].Proteins in central nervous tissue or connective tissue
contain isoaspartyl sites [38]. In addition, isoaspartyl resi- Damage accumulation in the form of isoaspartyl resi-
dues in plasma proteins therefore can be ascribed todues have been recently reported to increase the immu-
nogenic properties of peptides [39]. The effects of deami- their increased structural instability in uremia, rather
than the effect of hyperhomocysteinemia, due to eitherdation on biological functions have been carefully
assessed: Deamidation indeed reduces the activity of reduced repair or direct binding of this amino acid to
macromolecules.several proteins, such as calmodulin, CD4, and human
growth hormone [6].
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